<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00725166</url>
  </required_header>
  <id_info>
    <org_study_id>0708102</org_study_id>
    <secondary_id>2008-A00374-51</secondary_id>
    <nct_id>NCT00725166</nct_id>
  </id_info>
  <brief_title>Human Muscle Gene Expression Profiles in Young and Old Men</brief_title>
  <acronym>CERA</acronym>
  <official_title>Human Muscle Gene Expression Profiles in Young and Old Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation des Caisses d'Epargne Rhône-Alpes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Recherche Agronomique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To reach the goals of living longer in better medical conditions, many countries reach the
      same conclusion: new strategies have to be developed to avoid, or at least limit, the effects
      of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on
      the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably
      leads to impaired mobility and poor balance, which contributes to loss of functional autonomy
      and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a
      reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic
      effects such as frailty among elderly persons. The precise mechanisms of muscle aging are
      still mostly unknown, although many theories have been proposed.

      The present study aims at better understanding the mechanisms of skeletal muscle loss
      associated with aging. Using muscle biopsies from young and old subjects, the differential
      expression profiles of mRNA will be obtained through chips that will evaluate more than 39000
      transcripts. On the same samples, proteomic analyses will involve two complementary
      approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF)
      for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating
      proteins not detectable using 2DGE. Complementary histological studies
      (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major
      biomarkers in the muscle biopsies.

      The results of that research will have applications in the medium term and will lead to
      nutritional interventions to modulate specific metabolic pathways and improve the quality of
      life in the elderly.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify the differential expression profiles (proteomics, transcriptomics) in skeletal muscle between young and old men</measure>
    <time_frame>During biopsie (W3)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To specify the localisation of the major biomarkers in the muscle biopsies.</measure>
    <time_frame>During biopsie (W3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare muscular energy metabolic enzymatic activities between young and old men</measure>
    <time_frame>during biopsie (W3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the number of muscular stem cells between young and old men</measure>
    <time_frame>during biopsie (W3)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">41</enrollment>
  <condition>Elderly</condition>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Young</arm_group_label>
    <description>Young men 19-25 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old</arm_group_label>
    <description>old men 70-76 years old, who participate in the PROOF study (NCT 00759304)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Skeletal muscle aging</intervention_name>
    <description>W1 - Blood test
Maximal voluntary contraction of quadriceps
Hydrostatic weighing
W2 - Maximal metabolic test using a cycloergometer
W3 - Muscular biopsy</description>
    <arm_group_label>Young</arm_group_label>
    <arm_group_label>Old</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, muscle
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Young : students of the Saint-Etienne's university. Old : men who participate in the PROOF
        study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Affiliated or beneficiary of a social security category

          -  Having signed the inform consent form

          -  Having signed the genetic consent form

        Exclusion Criteria:

          -  Antiaggregant platelet treatment

          -  Type 2 diabetes

          -  Body Mass Index &gt; 25

          -  Severe renal disease

          -  CRP &gt; 10

          -  Abnormal clotting test

          -  Allergies to local anesthetics
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>76 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel BECHET, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>INRA Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Claude BARTHELEMY, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2008</study_first_submitted>
  <study_first_submitted_qc>July 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <last_update_submitted>June 9, 2009</last_update_submitted>
  <last_update_submitted_qc>June 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>Clément CAILLAUX</name_title>
    <organization>CHU de Saint-Etienne</organization>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Biopsy</keyword>
  <keyword>Skeletal muscle</keyword>
  <keyword>Molecular biology</keyword>
  <keyword>Genetic markers</keyword>
  <keyword>Gene expression regulation</keyword>
  <keyword>Young and old men</keyword>
  <keyword>Healthy volunteers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

